The National Kidney Foundation announced the latest investment from its Innovation Fund, the philanthropic impact investment program of NKF. Relavo, a female-founded company dedicated to making home dialysis more accessible, will receive an investment to further develop its PeritoneX® technology to make peritoneal dialysis (PD) safer for patients. The amount of investment was not disclosed.
PD is a form of treatment for kidney failure. It allows patients to receive treatment daily from the comfort of their own homes instead of spending 15-20 hours a week in a dialysis clinic.
Launched in 2022, the NKF Innovation Fund works to accelerate funding, development, and commercialization of therapies that kidney patients need and deserve. The fund invests in early to mid-stage companies that are developing innovative, patient-centric kidney therapies. Read more.
